Core Insights - Extendicare Inc. reported strong financial results for Q4 and the full year 2025, highlighting a 15.3% organic growth in the home health segment and a 5% increase in monthly dividends [3][15][13] Financial Performance - Q4 2025 revenue increased by $70.5 million or 18.0% to $462.0 million, driven by acquisitions and home health care growth [16][31] - Adjusted EBITDA for Q4 2025 rose by $12.2 million or 36.4% to $45.6 million, reflecting strong performance in the home health care segment [9][31] - Net earnings for Q4 2025 increased by $5.7 million or 28.4% to $25.6 million, primarily due to higher Adjusted EBITDA [16][32] Acquisition Strategy - Extendicare announced the acquisition of CBI Home Health for $570 million, expected to close in Q2 2026, which will enhance its service-focused growth strategy [5][6] - The acquisition is anticipated to generate annualized run-rate synergies of approximately $7.4 million, with an implied purchase price multiple of 8.4x CBI Home Health's Adjusted EBITDA after synergies [10][12] Dividend Policy - The company increased its monthly dividend by 5% to 4.41 cents per share, reflecting sustained operating performance and a strong capital structure [3][13] Business Segments - Home health care revenue for Q4 2025 increased by 33.6% to $197.5 million, with average daily volume (ADV) rising by 27.3% [24][25] - Long-term care revenue for Q4 2025 increased by 10.8% to $249.3 million, with NOI margin at 10.3% [21][23] Financial Position - As of December 31, 2025, Extendicare had cash and cash equivalents of $347.9 million, including net proceeds from a $200 million private placement [28][31] - The company secured a $214.5 million upsizing of its senior secured credit facility to support the CBI acquisition [6][29]
Extendicare Announces 2025 Fourth Quarter and Full Year Results and Dividend Increase